News & announcements
What's new at Isosceles.
Program milestones, partnership announcements, leadership appointments, and recognition from the broader scientific and business community.
Isosceles Pharmaceuticals Announces Acceptance of IPI201 for Phase I First-in-Human Clinical Trial
Press release · EIN PresswireAppoints Herbert Neuman, MD, MBA as Chief Medical Officer; Thomas Harrison joins as strategic advisor
Press releaseFeatured in business journal coverage of next-generation immuno-oncology adjuvants
Greater Wilmington Business JournalWins Coastal Entrepreneur Award, Biotechnology category
AwardFirst-place winner of the inaugural NC BIONEER Venture Challenge
AwardFor media inquiries or to request additional information on any of the items above, contact IR@isoscelespharma.com.